REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 108 filers reported holding REGENXBIO INC in Q4 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $60,331,892 | -18.5% | 3,665,364 | -1.0% | 0.01% | -12.5% |
Q2 2023 | $73,994,565 | -2.3% | 3,701,579 | -7.6% | 0.01% | -11.1% |
Q1 2023 | $75,746,000 | +87916.4% | 4,005,623 | +5.6% | 0.01% | -18.2% |
Q4 2022 | $86,059 | -99.9% | 3,794,477 | -6.4% | 0.01% | -26.7% |
Q3 2022 | $107,165,000 | +2.2% | 4,054,655 | -4.5% | 0.02% | 0.0% |
Q2 2022 | $104,849,000 | -33.1% | 4,244,896 | -10.2% | 0.02% | -21.1% |
Q1 2022 | $156,812,000 | -4.2% | 4,724,693 | -5.6% | 0.02% | 0.0% |
Q4 2021 | $163,656,000 | -5.7% | 5,004,773 | +20.9% | 0.02% | -9.5% |
Q3 2021 | $173,562,000 | +20.0% | 4,140,326 | +11.2% | 0.02% | +23.5% |
Q2 2021 | $144,594,000 | +21.1% | 3,721,845 | +6.3% | 0.02% | +6.2% |
Q1 2021 | $119,415,000 | +1.2% | 3,500,879 | +34.6% | 0.02% | -5.9% |
Q4 2020 | $117,998,000 | +112.9% | 2,601,366 | +31.0% | 0.02% | +88.9% |
Q3 2020 | $55,433,000 | -21.4% | 1,986,112 | +3.7% | 0.01% | -35.7% |
Q2 2020 | $70,550,000 | +44.9% | 1,915,561 | +27.4% | 0.01% | +27.3% |
Q1 2020 | $48,679,000 | -13.3% | 1,503,346 | +9.6% | 0.01% | +10.0% |
Q4 2019 | $56,176,000 | +28.0% | 1,371,134 | +11.2% | 0.01% | +11.1% |
Q3 2019 | $43,878,000 | -25.4% | 1,232,539 | +4.3% | 0.01% | -18.2% |
Q2 2019 | $58,787,000 | -14.9% | 1,182,134 | -1.9% | 0.01% | -21.4% |
Q1 2019 | $69,085,000 | +50.3% | 1,205,445 | +10.0% | 0.01% | +27.3% |
Q4 2018 | $45,968,000 | -43.0% | 1,095,825 | +2.6% | 0.01% | -26.7% |
Q3 2018 | $80,629,000 | +3.9% | 1,067,948 | -1.3% | 0.02% | -6.2% |
Q2 2018 | $77,633,000 | +75.8% | 1,082,006 | -26.8% | 0.02% | +77.8% |
Q1 2018 | $44,151,000 | -12.5% | 1,479,100 | -2.5% | 0.01% | -18.2% |
Q4 2017 | $50,437,000 | +23.7% | 1,516,908 | +19.4% | 0.01% | +22.2% |
Q3 2017 | $40,778,000 | +68.3% | 1,270,327 | +3.5% | 0.01% | +50.0% |
Q2 2017 | $24,230,000 | +6.8% | 1,226,835 | +4.3% | 0.01% | +20.0% |
Q1 2017 | $22,693,000 | +22.4% | 1,175,794 | +17.6% | 0.01% | +25.0% |
Q4 2016 | $18,546,000 | +30.7% | 999,747 | -1.3% | 0.00% | +33.3% |
Q3 2016 | $14,188,000 | +449.9% | 1,012,666 | +213.9% | 0.00% | +200.0% |
Q2 2016 | $2,580,000 | -27.9% | 322,582 | -2.6% | 0.00% | 0.0% |
Q1 2016 | $3,579,000 | -39.9% | 331,340 | -7.6% | 0.00% | 0.0% |
Q4 2015 | $5,955,000 | +23.7% | 358,752 | +64.2% | 0.00% | 0.0% |
Q3 2015 | $4,813,000 | – | 218,474 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |